15473963|t|The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer's disease.
15473963|a|Amyloid beta-peptide (Abeta) accumulation in specific brain regions is a pathological hallmark of Alzheimer's disease (AD). We have previously reported that a well-characterized acyl-coenzyme A: cholesterol acyltransferase (ACAT) inhibitor, CP-113,818, inhibits Abeta production in cell-based experiments. Here, we assessed the efficacy of CP-113,818 in reducing AD-like pathology in the brains of transgenic mice expressing human APP(751) containing the London (V717I) and Swedish (K670M/N671L) mutations. Two months of treatment with CP-113,818 reduced the accumulation of amyloid plaques by 88%-99% and membrane/insoluble Abeta levels by 83%-96%, while also decreasing brain cholesteryl-esters by 86%. Additionally, soluble Abeta(42) was reduced by 34% in brain homogenates. Spatial learning was slightly improved and correlated with decreased Abeta levels. In nontransgenic littermates, CP-113,818 also reduced ectodomain shedding of endogenous APP in the brain. Our results suggest that ACAT inhibition may be effective in the prevention and treatment of AD by inhibiting generation of the Abeta peptide.
15473963	4	8	ACAT	Gene	110446
15473963	19	29	CP-113,818	Chemical	MESH:C087132
15473963	47	54	amyloid	Disease	MESH:C000718787
15473963	70	75	mouse	Species	10090
15473963	85	104	Alzheimer's disease	Disease	MESH:D000544
15473963	128	133	Abeta	Gene	11820
15473963	204	223	Alzheimer's disease	Disease	MESH:D000544
15473963	225	227	AD	Disease	MESH:D000544
15473963	284	328	acyl-coenzyme A: cholesterol acyltransferase	Gene	1066
15473963	330	334	ACAT	Gene	1066
15473963	347	357	CP-113,818	Chemical	MESH:C087132
15473963	368	373	Abeta	Gene	11820
15473963	446	456	CP-113,818	Chemical	MESH:C087132
15473963	469	471	AD	Disease	MESH:D000544
15473963	515	519	mice	Species	10090
15473963	531	536	human	Species	9606
15473963	569	574	V717I	ProteinMutation	tmVar:p|SUB|V|717|I;HGVS:p.V717I;VariantGroup:0;CorrespondingGene:351;RS#:63750264;CorrespondingSpecies:9606;CA#:127791
15473963	589	594	K670M	ProteinMutation	tmVar:p|SUB|K|670|M;HGVS:p.K670M;VariantGroup:1;CorrespondingGene:351;CorrespondingSpecies:9606
15473963	595	600	N671L	ProteinMutation	tmVar:p|SUB|N|671|L;HGVS:p.N671L;VariantGroup:2;CorrespondingGene:351;CorrespondingSpecies:9606
15473963	642	652	CP-113,818	Chemical	MESH:C087132
15473963	681	696	amyloid plaques	Disease	MESH:D058225
15473963	731	736	Abeta	Gene	11820
15473963	784	802	cholesteryl-esters	Chemical	MESH:D002788
15473963	833	842	Abeta(42)	Gene	351
15473963	953	958	Abeta	Gene	351
15473963	997	1007	CP-113,818	Chemical	MESH:C087132
15473963	1098	1102	ACAT	Gene	1066
15473963	1166	1168	AD	Disease	MESH:D000544
15473963	1201	1206	Abeta	Gene	11820
15473963	Negative_Correlation	MESH:C087132	351
15473963	Association	MESH:D000544	11820
15473963	Association	1066	11820
15473963	Negative_Correlation	MESH:C087132	MESH:D002788
15473963	Negative_Correlation	MESH:C087132	MESH:D058225
15473963	Negative_Correlation	MESH:C087132	11820
15473963	Association	MESH:D000544	1066
15473963	Negative_Correlation	MESH:C087132	MESH:D000544
15473963	Negative_Correlation	MESH:C087132	MESH:C000718787
15473963	Negative_Correlation	MESH:C087132	1066
15473963	Negative_Correlation	MESH:C087132	110446

